Beth Israel Deaconess Medical Center: Weight Loss Drugs Linked to Lower Risk of Peptic Ulcer Disease in Adults With Diabetes
April 30, 2026
April 30, 2026
BOSTON, Massachusetts, April 30 (TNSjou) -- Beth Israel Deaconess Medical Center issued the following news:
* * *
Weight Loss Drugs Linked to Lower Risk of Peptic Ulcer Disease in Adults with Diabetes
GLP1 Receptor Agonists were Associated with Fewer Ulcer Diagnoses in Large U.S. Study
*
Medications widely prescribed for type 2 diabetes and weight management may offer an unexpected benefit for the gut. A large nationwide study led . . .
* * *
Weight Loss Drugs Linked to Lower Risk of Peptic Ulcer Disease in Adults with Diabetes
GLP1 Receptor Agonists were Associated with Fewer Ulcer Diagnoses in Large U.S. Study
*
Medications widely prescribed for type 2 diabetes and weight management may offer an unexpected benefit for the gut. A large nationwide study led . . .